Standout Papers

Canagliflozin Compared With Sitagliptin for Patients With Type 2 Diabetes Who Do Not Have Adequate... 2013 2026 2017 2021 395
  1. Canagliflozin Compared With Sitagliptin for Patients With Type 2 Diabetes Who Do Not Have Adequate Glycemic Control With Metformin Plus Sulfonylurea (2013)
    Guntram Schernthaner, Jorge Luiz Gross et al. Diabetes Care

Immediate Impact

1 from Science/Nature 104 standout
Sub-graph 1 of 20

Citing Papers

Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes
2025 Standout
Gliflozins in the Management of Cardiovascular Disease
2022 Standout
10 intermediate papers

Works of Jacqueline Yee being referenced

Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes on background metformin and pioglitazone
2014
Canagliflozin Compared With Sitagliptin for Patients With Type 2 Diabetes Who Do Not Have Adequate Glycemic Control With Metformin Plus Sulfonylurea
2013 Standout
and 2 more

Author Peers

Author Last Decade Papers Cites
Jacqueline Yee 468 861 36 348 22 1.2k
Ewa Wajs 478 805 79 352 45 1.4k
Julie Rask Larsen 278 639 216 138 28 1.1k
Delphine Hennicken 252 522 11 324 13 1.0k
Katrin Hücking 467 799 70 339 15 1.3k
Liselotte van Bloemendaal 237 658 25 293 21 1.3k
Jens D. Kristensen 363 315 40 208 30 1.2k
Corina Loghin 325 766 19 441 21 1.2k
J. C. Laidlaw 331 664 38 273 27 971
Amy E. Rothberg 395 399 57 195 57 1.3k
Jeremy Gilbert 294 481 224 183 41 1.2k

All Works

Loading papers...

Rankless by CCL
2026